83 related articles for article (PubMed ID: 7495982)
1. Rodent models for the study of etiology, prevention and treatment of breast cancer.
Gould MN
Semin Cancer Biol; 1995 Jun; 6(3):147-52. PubMed ID: 7495982
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mouse models for the prevention of breast cancer.
Shen Q; Brown PH
Mutat Res; 2005 Aug; 576(1-2):93-110. PubMed ID: 15888345
[TBL] [Abstract][Full Text] [Related]
3. Mouse models of transforming growth factor beta impact in breast development and cancer.
Serra R; Crowley MR
Endocr Relat Cancer; 2005 Dec; 12(4):749-60. PubMed ID: 16322320
[TBL] [Abstract][Full Text] [Related]
4. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD
Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements.
Malewicz B; Wang Z; Jiang C; Guo J; Cleary MP; Grande JP; Lü J
Carcinogenesis; 2006 Sep; 27(9):1739-47. PubMed ID: 16597642
[TBL] [Abstract][Full Text] [Related]
6. Roles for estrogen and progesterone in breast cancer prevention.
Jerry DJ
Breast Cancer Res; 2007; 9(2):102. PubMed ID: 17381827
[TBL] [Abstract][Full Text] [Related]
7. New rodent models for studies of chemopreventive agents.
Lipkin M
J Cell Biochem Suppl; 1997; 28-29():144-7. PubMed ID: 9589360
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer.
Tsubura A; Uehara N; Matsuoka Y; Yoshizawa K; Yuri T
In Vivo; 2008; 22(2):191-201. PubMed ID: 18468403
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
10. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
[TBL] [Abstract][Full Text] [Related]
11. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular aspects of the multistage progression of mammary carcinogenesis in humans and rats.
Gould MN
Semin Cancer Biol; 1993 Jun; 4(3):161-9. PubMed ID: 8318692
[TBL] [Abstract][Full Text] [Related]
13. Mouse models and breast cancer.
Robinson A
CMAJ; 1995 Oct; 153(8):1123-4. PubMed ID: 7553521
[TBL] [Abstract][Full Text] [Related]
14. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of two rat mammary tumour models for breast cancer research by gene expression profiling.
Marxfeld H; Staedtler F; Harleman JH
Exp Toxicol Pathol; 2006 Nov; 58(2-3):133-43. PubMed ID: 16857353
[TBL] [Abstract][Full Text] [Related]
16. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
17. HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.
Chan T; Sami A; El-Gayed A; Guo X; Xiang J
Gene Ther; 2006 Oct; 13(19):1391-402. PubMed ID: 16724093
[TBL] [Abstract][Full Text] [Related]
18. Validity of mouse mammary tumour models for human breast cancer: comparative pathology.
Cardiff RD
Microsc Res Tech; 2001 Jan; 52(2):224-30. PubMed ID: 11169869
[TBL] [Abstract][Full Text] [Related]
19. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.
Pulaski BA; Ostrand-Rosenberg S
Cancer Res; 1998 Apr; 58(7):1486-93. PubMed ID: 9537252
[TBL] [Abstract][Full Text] [Related]
20. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy.
Blakely CM; Stoddard AJ; Belka GK; Dugan KD; Notarfrancesco KL; Moody SE; D'Cruz CM; Chodosh LA
Cancer Res; 2006 Jun; 66(12):6421-31. PubMed ID: 16778221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
